Mycobacterium tuberculosis is a successful pathogen that overcomes numerous challenges presented by the immune system of the host. This bacterium usually establishes a chronic infection in the host where it may silently persist inside a granuloma until, a failure in host defenses, leads to manifestation of the disease. None of the conventional anti-tuberculosis drugs are able to target these persisting bacilli. Development of drugs against such persisting bacilli is a constant challenge since the physiology of these dormant bacteria is still not understood at the molecular level. Some evidence suggests that the in vivo environment encountered by the persisting bacteria is anoxic and nutritionally starved. Based on these assumptions, anaerob...
Depletion of oxygen levels is a well-accepted model for induction of non-replicating, persistent sta...
Mycobacterium tuberculosis is a globally successful pathogen, infecting more than one third of total...
SummaryMycobacterium tuberculosis (Mtb) defends itself against host immunity and chemotherapy at sev...
Mycobacterium tuberculosis is a successful pathogen that overcomes numerous challenges presented by ...
A key feature of Mycobacterium tuberculosis is its ability to become dormant in the host. Little is ...
The success of M. tuberculosis lies in its ability to stay alive and persist in a potentially hostil...
Mycobacterium tuberculosis remains a major human health problem killing millions of people around th...
Mycobacterium tuberculosis is a prototrophic, metabolically flexible bacterium that has achieved a s...
A key feature of Mycobacterium tuberculosis is its ability to become dormant in the host. Little is ...
The logistics of tuberculosis therapy are difficult, requiring multiple drugs for many months. Mycob...
The majority of individuals infected with TB develop a latent infection, in which organisms survive ...
<div><p>A key feature of <i>Mycobacterium tuberculosis</i> is its ability to become dormant in the h...
Mycobacterium tuberculosis is able to persist in the human host for decades in an apparently dormant...
BACKGROUND:Mycobacterium tuberculosis (Mtb) becomes dormant and phenotypically drug resistant when i...
Tuberculosis remains one of the oldest diseases known to mankind but still persists as a very major ...
Depletion of oxygen levels is a well-accepted model for induction of non-replicating, persistent sta...
Mycobacterium tuberculosis is a globally successful pathogen, infecting more than one third of total...
SummaryMycobacterium tuberculosis (Mtb) defends itself against host immunity and chemotherapy at sev...
Mycobacterium tuberculosis is a successful pathogen that overcomes numerous challenges presented by ...
A key feature of Mycobacterium tuberculosis is its ability to become dormant in the host. Little is ...
The success of M. tuberculosis lies in its ability to stay alive and persist in a potentially hostil...
Mycobacterium tuberculosis remains a major human health problem killing millions of people around th...
Mycobacterium tuberculosis is a prototrophic, metabolically flexible bacterium that has achieved a s...
A key feature of Mycobacterium tuberculosis is its ability to become dormant in the host. Little is ...
The logistics of tuberculosis therapy are difficult, requiring multiple drugs for many months. Mycob...
The majority of individuals infected with TB develop a latent infection, in which organisms survive ...
<div><p>A key feature of <i>Mycobacterium tuberculosis</i> is its ability to become dormant in the h...
Mycobacterium tuberculosis is able to persist in the human host for decades in an apparently dormant...
BACKGROUND:Mycobacterium tuberculosis (Mtb) becomes dormant and phenotypically drug resistant when i...
Tuberculosis remains one of the oldest diseases known to mankind but still persists as a very major ...
Depletion of oxygen levels is a well-accepted model for induction of non-replicating, persistent sta...
Mycobacterium tuberculosis is a globally successful pathogen, infecting more than one third of total...
SummaryMycobacterium tuberculosis (Mtb) defends itself against host immunity and chemotherapy at sev...